Omacetaxine for Consolidation and Maintenance

计划入组 7 人 · 首次发布于 2013 年 6 月 10 日

Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS

计划入组 28 人 · 首次发布于 2018 年 6 月 21 日

Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)

计划入组 6 人 · 首次发布于 2021 年 6 月 15 日

Omacetaxine mepesuccinate(Synribo)

C₂₉H₃₉NO₉ · Rx

Omacetaxine Plus Azacitidine Shows Favorable Safety and Long-Term Outcomes in Advanced MDS

Quizartinib Combination Therapy Shows Promise in Phase II Trial for FLT3-ITD AML

Asciminib's Rising Prominence and Evolving Treatment Strategies in Chronic Myeloid Leukemia